News about Kyverna Therapeutics Inc

Investors Urged to Act Legal Counsel Needed Before February Deadline for Kyverna Therapeutics Securities Class Action
Jan 31 2025
In an urgent alert, the Rosen Law Firm, a highly recognized entity in the field of investor rights, has prompted investors of Kyverna Therapeutics, In...

Class Action Looms Over Kyverna Therapeutics, Inc. with February Deadline for Lead Plaintiffs
Dec 30 2024
In a significant development for stakeholders of Kyverna Therapeutics, Inc. investors are being alerted to an impending class action lawsuit against t...

Kyverna Therapeutics Investors Advised to Seek Counsel Ahead of Securities Class Action Deadline
Dec 30 2024
In a recent development significant to investors in the biotechnology sector, Rosen Law Firm, a prominent global investor rights law firm, has issued ...

Deadline Looms for Kyverna Therapeutics Investors in Class Action Suit
Dec 26 2024
Rosen Law Firm Urges Kyverna Therapeutics Investors to Take Legal Action by February Deadline In the turbulent world of biotechnology finance, investo...

Legal Implications of Kyverna Therapeutics IPO A Crucial Notice for Investors
Dec 21 2024
In the evolving landscape of biotech investments, the recent announcement from Rosen Law Firm regarding Kyverna Therapeutics, Inc. (NASDAQ: KYTX) has...

Rosen Law Firm Urges Kyverna Therapeutics Investors to Act Before Critical February 2025 Deadline in Securities...
Dec 14 2024
Legal Advisory: Rosen Law Firm Urges Kyverna Therapeutics Investors to Secure Counsel Ahead of Important Deadline in Securities Class Action In the c...

From Lab to Lawsuit The Delicate Balance of Kyverna Therapeutics,
Dec 12 2024
Falling Under the Microscope: The Kyverna Therapeutics Class Action LawsuitIn an unfolding drama that intertwines the pharmaceutical world with the l...